BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 16/02/2018

FDA Announces Draft Guidance for ALS Drug Development

The FDA has released a draft guidance to help pharmaceutical companies develop drugs for treating amyotrophic lateral sclerosis (ALS), a progressive neurological disease characterized by muscle weakness and shortened survival.

Source: Federal Register — Food and Drug AdministrationOpen original release →